New Delhi: Department of Pharmaceuticals Secretary Arunish Chawla on Tuesday said the government and industry should work together to reduce import dependence in the medical devices sector by 50 per cent in the next five years.

Highlighting the critical need to focus on quality to ensure that India becomes globally competitive, he said the government is working to formulate standards to make the more than 2,000 medical devices produced in the country globally competitive. Is in process.

Speaking to reporters here, Chawla said, "Right now our medical-tech sector is 75-80 per cent dependent on imports. In the next five years, we want to reduce this import dependence to 50 per cent." An industry program to create better policies for the sector.Chawla said discussions were also held to increase medical device exports to match the level of imports of SUC articles in the country during the Meditech Staccato 2024.

Emphasizing the need to produce quality products for global markets, he said the government is trying to raise the standards of the manufacturing process.

Chawla said, "Zero defects, full efficacy, this is our mission. Through BIS, we are creating product standards for medical devices which will be at par with ISO. We have already set standards for 1,500 products.,

He said that the process of preparing standards for about 500 products is going on.

Chawla said the industry is also focusing on creating quality systems to obtain export certification which is followed in foreign markets.

He said that PLI scheme for medical devices has played an important role in the growth of this sector.

"Around 150 medical equipment, which were earlier imported, are now being produced in the country...even export of such products has now started," Chawla said.

He said exports in consumables and disposables have outpaced imports over the past year, and urged the industry to continue the momentum in other pillars of the med-tech sector.India's med tech industry is poised to grow from the current level of US$14 billion to US$50 billion by 2030. India is currently the fourth largest market in Asia for medical devices and among the top 20 globally.

Net imports for 2022-23 stood at US$ 4,101 million.

The Department of Pharmaceuticals has organized the Meditech Stackathon 2024 in collaboration with the Confederation of Indian Industry (CII).

Himanshu Baid, President, CII National Medical Technology Forum, highlighted the need for improved data compilation mechanisms to address the gap in product consumption and production within India.He said India's medical-tech landscape is full of potential and is poised to achieve 10 per cent global market share in the next decade.